Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2009
10/27/2009US7608270 Dosage form
10/27/2009US7608263 RG1 antibodies and uses thereof
10/27/2009US7608253 end-capped polyethylene glycol carbamate derivatives useful as water-soluble pro-drugs; controll hydrolytic degradation of hydrogels; conjugate polymer drug for controlled release
10/27/2009US7608245 Transmission and, or amplification of signal ; oral or enteric administering; dissolving; absorption by small inteestines; peptide yy; obesity therapy
10/27/2009CA2520813C Sustained release formulations of alkylene dioxybenzene derivatives useful as 5-ht1a agonists
10/27/2009CA2473393C Semi-fluorinated alkanes and their use
10/27/2009CA2430318C Powder formulation and method for producing the same
10/27/2009CA2392741C Surfactants as malarial chloroquine resistance reversal agents
10/27/2009CA2363792C Percutaneous absorption preparation of compound having angiotensin ii antagonistic activity
10/27/2009CA2338141C Polymer complexes of glucuronoglucanes
10/27/2009CA2319837C Hydroxylation activated drug release
10/27/2009CA2299687C Temperature-controlled ph-dependant formation of ionic polysaccharide gels
10/27/2009CA2163364C Self-assembling polynucleotide delivery system comprising dendrimer polycations
10/27/2009CA2162366C Conjugation-stabilized polypeptide compositions
10/27/2009CA2067205C Vaccine and immune serum against drugs of abuse
10/25/2009CA2629979A1 Novel resveratrol compositions
10/22/2009WO2009129531A2 Bupivacaine formulation in a polyorthoester carrier
10/22/2009WO2009129519A2 Benzodiazepine formulation in a polyorthoester carrier
10/22/2009WO2009129511A2 Fluocinolone formulations in a biodegradable polymer carrier
10/22/2009WO2009129509A2 Methods and compositions for treating post-operative pain comprising a local anesthetic
10/22/2009WO2009129494A2 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009WO2009129491A2 Beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009WO2009129476A2 An antibody bound synthetic vesicle containing active agent molecules
10/22/2009WO2009129456A2 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
10/22/2009WO2009129453A2 Clonidine formulation in a polyorthoester carrier
10/22/2009WO2009129433A2 Alpha adrenergic receptor agonists for treatment of degenerative disc disease
10/22/2009WO2009129336A2 Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
10/22/2009WO2009129246A2 Compositions and methods for preparing and using same
10/22/2009WO2009129163A2 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use
10/22/2009WO2009129155A2 Dexamethasone formulations in a biodegradable material
10/22/2009WO2009129149A2 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
10/22/2009WO2009129148A2 Methods and compositions for treating intervertebral disc herniations
10/22/2009WO2009129145A2 Sulfasalazine formulations in a biodegradable polymer carrier
10/22/2009WO2009129101A1 Liquid buffered gdf-5 formulations
10/22/2009WO2009129094A2 Compositions containing antiviral compounds and methods of using the same
10/22/2009WO2009128951A2 Compositions of respiratory synctial virus proteins and methods of use
10/22/2009WO2009128918A1 Combination therapy using a soluble hyaluronidase and a bisphosphonate
10/22/2009WO2009128789A1 Vesicles for intracellular drug delivery
10/22/2009WO2009128543A1 Process for producing silica-containing tablet, tablet, and composite particle for tablet
10/22/2009WO2009128489A1 Tablet containing vancomycin hydrochloride
10/22/2009WO2009128474A1 Method of producing thrombin-immobilized bioabsorbable sheet preparation
10/22/2009WO2009128433A1 Film-like composition
10/22/2009WO2009128357A1 Bioactive protein-containing nanoparticle composition and method for producing the same
10/22/2009WO2009128273A1 Iontophoresis preparation for treating breast cancer and/or mastitis
10/22/2009WO2009127922A2 Pharmaceutical formulation for treating cardiovascular disease
10/22/2009WO2009127878A1 A liquid spray solution comprising buprenorphine, ethanol and an antioxidant
10/22/2009WO2009127830A1 Compositions for the treatment of lice
10/22/2009WO2009127072A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
10/22/2009WO2009127059A1 Complexes of isogranulatimide and granulatimide with a cyclodextrm, formulations and their use for the treatment of cancer
10/22/2009WO2009127046A1 Prostate specific membrane antigen antibodies and antigen binding fragments
10/22/2009WO2009126980A1 Cellulose-based hydrogel and process for producing it
10/22/2009WO2009108891A3 Modified poloxamers for gene expression and associated methods
10/22/2009WO2009102121A3 Solid lipid nanoparticles for drug delivery, a production method therefor, and an injectable preparation comprising the nanoparticles
10/22/2009WO2009100351A8 Delivery of rnai constructs to oligodendrocytes
10/22/2009WO2009097017A3 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof
10/22/2009WO2009087483A3 Pharmaceutical formulations
10/22/2009WO2009084975A8 Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity
10/22/2009WO2009030439A3 Method for the production of quick mineral agglomerates (mbda, micro bubbles distorted agglomerates)
10/22/2009WO2009022174A3 Non-aggregating virus formulation
10/22/2009WO2009003110A3 Metap-2 inhibitor polϋmersomes for therapeutic administration
10/22/2009WO2008126092A3 Compositions and methods for scaffold formation
10/22/2009WO2002044329A9 Receptor-mediated uptake of peptides that bind the human transferrin receptor
10/22/2009US20090264636 Conjugates and compositions for cellular delivery
10/22/2009US20090264629 Stabilized protein-containing formulations
10/22/2009US20090264627 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents
10/22/2009US20090264541 Cosmetic composition comprising an oil
10/22/2009US20090264540 Novel derivatives of cyclodextrins, process for their preparation and their use in particular for solubilizing pharmacologically active substances
10/22/2009US20090264539 Fluoropolymer-based medical implant coating compositions
10/22/2009US20090264538 Multifunctional polymeric tissue coatings
10/22/2009US20090264537 Biodegradable block copolymeric compositions for drug delivery
10/22/2009US20090264521 Percutaneous absorption preparation
10/22/2009US20090264389 Method of preparing dry powder inhalation compositions
10/22/2009US20090264385 Stabilized compositions containing alkaline labile drugs
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264367 5-cnac as oral delivery agent for parathyroid hormone fragments
10/22/2009US20090264340 Compositions and methods for increasing the oral absorption of antimicrobials
10/22/2009US20090263497 Production method for calcium phosphate nano-particles with high purity and their use
10/22/2009US20090263488 Pressurised metered dose inhalers containing solutions of beta-2 agonists
10/22/2009US20090263484 Tissue Engineering Devices and Methods for Luminal Organs
10/22/2009US20090263479 Formulations for poorly permeable active pharmaceutical ingredients
10/22/2009US20090263470 Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant
10/22/2009US20090263445 Medical devices comprising spray dried microparticles
10/22/2009US20090263429 Method of Preparing a Hydrogel
10/22/2009US20090263408 Formulation and presentation of medicaments
10/22/2009US20090263407 Cationic Lipids and Uses Thereof
10/22/2009US20090263346 Systems and methods for delivery of drugs
10/22/2009US20090263320 Peptide-Based Compounds
10/22/2009DE102008019303A1 Skin protection composition, useful e.g. as agent for preventing or treating callus and blisters, comprises a polymerization mixture, which is hardenable under the influence of light, e.g. polyester(meth)acrylate or polyolacrylate
10/22/2009CA2721649A1 Compositions for the treatment of lice
10/22/2009CA2721586A1 Compositions containing antiviral compounds and methods of using the same
10/22/2009CA2721568A1 An antibody bound synthetic vesicle containing active agent molecules
10/22/2009CA2721335A1 Process for preparing bioabsorbable sheet preparation holding thrombin
10/22/2009CA2721169A1 Prostate specific membrane antigen antibodies and antigen binding fragments
10/22/2009CA2721019A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
10/22/2009CA2720990A1 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009CA2720845A1 Liquid buffered gdf-5 formulations
10/22/2009CA2720671A1 Compositions and methods for preparing and using same
10/22/2009CA2720670A1 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use
10/22/2009CA2720203A1 Osteogenic composition including a complex growth factor/amphiphilic polymer, a soluble cation salt, and an organic substrate
10/22/2009CA2700736A1 Methods and compositions for treating post-operative pain comprising a local anesthetic
1 ... 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 ... 1712